Chamaejasmine inactivates Akt to trigger apoptosis in human HEp-2 larynx carcinoma cells

Molecules

Volumn 16, Issue 10, 2011, Pages 8152-8164

  Wang, Yu ^a   Zhao, Yan ^a   Liu, Ying ^a   Tian, Linli ^a   Jin, Dejun ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Akt; Apoptosis; Chamaejasmine; HEp 2; In vivo

Indexed keywords

ANTINEOPLASTIC AGENT; APIGENIN; BAD PROTEIN, HUMAN; BIFLAVONOID; CASPASE 3; CASPASE 9; CHAMAEJASMIN; GLYCOGEN SYNTHASE KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BAD; PROTEIN KINASE B; SOMATOMEDIN C RECEPTOR;

ANIMAL; APOPTOSIS; ARTICLE; BIOSYNTHESIS; CELL STRAIN HEK293; CELL SURVIVAL; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; HUMAN; LARYNX TUMOR; METABOLISM; MOUSE; NUDE MOUSE; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APIGENIN; APOPTOSIS; BCL-ASSOCIATED DEATH PROTEIN; BIFLAVONOIDS; CASPASE 3; CASPASE 9; CELL LINE, TUMOR; CELL SURVIVAL; FEMALE; GLYCOGEN SYNTHASE KINASE 3; HEK293 CELLS; HUMANS; LARYNGEAL NEOPLASMS; MICE; MICE, NUDE; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, IGF TYPE 1; SIGNAL TRANSDUCTION;

EID: 80054912021     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules16108152     Document Type: Article

References (36)

1. Massano, J.; Regaterio, F. S.; Januario, G.; Ferreira, A. Oral squamous cell carcinoma: Review of prognostic and predictive factors. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 2006, 102, 67-76. (Pubitemid 44016111)
2. Hoffman, H. T.; Porter, K.; Karnell, L. H.; Cooper, J. S.; Weber, R. S.; Langer, C. J.; Ang, K. K.; Gay, G.; Stewart, A.; Robinson, R. A. Laryngeal cancer in the United States: Changes in demographics, patterns of care, and survival. Laryngoscope 2006, 116, 1-13. (Pubitemid 44337830)
3. Friboulet, L.; Pioche-Durieu, C.; Rodriguez, S.; Valent, A.; Souquère, S.; Ripoche, H.; Khabir, A.; Tsao, S. W.; Bosq, J.; Lo, K. W.; Busson, P. Recurrent over-expression of c-IAP2 in EBV-associated nasopharyngeal carcinomas: Critical role in resistance to Toll-like receptor 3-mediated apoptosis. Neoplasia 2008, 10, 1183-1194.
4. Lefebvre, J. L.; Ang, K. K.; Larynx Preservation Consensus Panel. Larynx preservation clinical trial design: Key issues and recommendations-a consensus panel summary. Int. J. Radiat. Oncol. Biol. Phys. 2009, 73, 1293-1303.
5. de Petris, L.; Crino, L.; Scagliotti, G. V.; Gridelli, C.; Galetta, D.; Metro, G.; Novello, S.; Maione, P.; Colucci, G.; de Marinis, F. Treatment of advanced non-small cell lung cancer. Ann. Oncol. 2006, 2, ii36-ii41.
6. Bellacosa, A.; Testa, J. R.; Staal, S. P.; Tsichlis, P. N. A retroviral oncogene, akt, encoding a serinethreonine kinase containing an SH2-like region. Science 1991, 254, 274-277. (Pubitemid 21917339)
7. Fayard, E.; Tintignac, L. A.; Baudry, A.; Hemmings, B. A. Protein kinase B/Akt at a glance. J. Cell Sci. 2005, 118, 5675-5678. (Pubitemid 43079259)
8. Staal, S. P.; Hartley, J. W.; Rowe, W. P. Isolation of transforming murine leukemia viruses from mice with a high incidence of spontaneous lymphoma. Proc. Natl. Acad. Sci. USA 1977, 74, 3065-3067. (Pubitemid 8132494)
9. Garofalo, R. S.; Orena, S. J.; Rafidi, K.; Torchia, A. J.; Stock, J. L.; Hildebrandt, A. L.; Coskran, T.; Black, S. C.; Brees, D. J.; Wicks, J. R.; McNeish, J. D.; Coleman, K. G. Severe diabetes, agedependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKB beta. J. Clin. Invest. 2003, 112, 197-208. (Pubitemid 38056356)
10. Yang, Z. Z.; Tschopp, O.; Baudry, A.; Dümmler, B.; Hynx, D.; Hemmings, B. A. Physiological functions of protein kinase B/Akt. Biochem. Soc. Trans. 2004, 32, 350-354. (Pubitemid 38582126)
11. Luo, J.; Manning, B. D.; Cantley, L. C. Targeting the PI3K-Akt pathway in human cancer: Rationale and promise. Cancer Cell 2003, 4, 257-262. (Pubitemid 37329790)
12. Manning, B. D.; Cantley, L. C. AKT/PKB signaling: Navigating downstream. Cell 2007, 129, 1261-1274. (Pubitemid 46962095)
13. Testa, J. R.; Tsichlis, P. N. AKT signaling in normal and malignant cells. Oncogene 2005, 24, 7391-7393. (Pubitemid 41637978)
14. Li, J.; Yen, C.; Liaw, D.; Podsypanina, K.; Bose, S.; Wang, S.; Puc, J.; Miliaresis, C.; Rodgers, L.; McCombie, R.; Bigner, S. H.; Giovanella, B. C.; Ittmann, M.; Tycko, B.; Hibshoosh, H.; Wigler, M. H.; Parsons, R. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 1997, 275, 1943-1947. (Pubitemid 27148818)
15. Blume-Jensen, P.; Hunter, T. Oncogenic kinase signalling. Nature 2001, 411, 355-365. (Pubitemid 32467045)
16. Mende, I.; Malstrom, S.; Tsichlis, P. N.; Vogt, P. K.; Aoki, M. Oncogenic transformation induced by membrane-targeted Akt2 and Akt3. Oncogene 2001, 20, 4419-4423. (Pubitemid 32726886)
17. Sun, M.; Wang, G.; Paciga, J. E.; Feldman, R. I.; Yuan, Z. Q.; Ma, X. L.; Shelley, S. A.; Jove, R.; Tsichlis, P. N.; Nicosia, S. V.; Cheng, J. Q. AKT1/PKBalpha kinase is frequently elevated in human cancers and its constitutive activation is required for oncogenic transformation in NIH3T3 cells. Am. J. Pathol. 2001, 159, 431-437. (Pubitemid 32751073)
18. Cheng, J. Q.; Lindsley, C. W.; Cheng, G. Z.; Yang, H.; Nicosia, S. V. The Akt/PKB pathway: Molecular target for cancer drug discovery. Oncogene 2005, 24, 7482-7492. (Pubitemid 41637988)
19. Hennessy, B. T.; Smith, D. L.; Ram, P. T.; Lu, Y.; Mills, G. B. Exploiting the PI3K/AKT pathway for cancer drug discovery. Nat. Rev. Drug Discov. 2005, 4, 988-1004.
20. Crowell, J. A.; Steele, V. E.; Fay, J. R. Targetting the AKT protein kinase for cancer chemoprevention. Mol. Cancer Ther. 2007, 6, 2139-2148. (Pubitemid 47294742)
21. Shi, Z. C. The Poisonous Plants in Chinese Pasture; China Agricultural Press: Beijing, China, 1997.
22. Zhao, S. H.; Wang, S. Q. Progress of investigations and application of insecticide plants. Guangdong Agric. Sci. 1997, 26-28.
23. Feng, W.; Ikekawa, T.; Yoshida, M. The antitumor activities of gnidimacrin isolated from stellera chamaejasme L. Chin. J. Can. Res. 1996, 8, 101-104.
24. Tang, X.; Hou, T. Development of chamaejasmin microemulsion and its biological activity against Aphis craccivora and Culex pipiens pallens. Flavour Fragr. J. 2008, 23, 258-262.
25. Fang, W.; Liu, S.; Nie, Y. Anticancer Activity of Chamaejasmine: Effect on Tubulin Protein. Molecules 2011, 16, 6243-6254.
26. Jing, Y.; Zhang, G. G.; Ma, E. L.; Zhang, H. M.; Guan, J.; He, J. Amentoflavone and the extracts from Selaginella tamariscina and their anticancer activity. Asian J. Tradit. Med. 2010, 5, 226-229.
27. Cross, D. A.; Alessi, D. R.; Cohen, P.; Andjelkovich, M.; Hemmings, B. A. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 1995, 378, 785-789. (Pubitemid 26004411)
28. Vivanco, I.; Sawyers, C. L. The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat. Rev. Cancer 2002, 2, 489-501. (Pubitemid 37328931)
29. Tanno, S.; Tanno, S.; Mitsuuchi, Y.; Altomare, D. A.; Xiao, G. H.; Testa, J. R. AKT Activation Up-Regulates Insulin-like Growth Factor I Receptor Expression and Promotes Invasiveness of Human Pancreatic. Cancer Cells 2001, 61, 589-593. (Pubitemid 32128619)
30. Macaulay, V. M. Insulin-like growth factors and cancer. Br. J. Cancer 1992, 65, 311-320.
31. Kaleko, M.; Rutter, W. J.; Miller, A. D. Overexpression of the human insulin like growth factor I receptor promotes ligand-dependent neoplastic transformation. Mol. Cell. Biol. 1990, 10, 464-473.
32. Sell, C.; Baserga, R.; Rubin, R. Insulin-like growth factor I (IGF-I) and the IGF-I receptor prevent etoposide-induced apoptosis. Cancer Res. 1995, 55, 303-306.
33. Henshall, D. C.; Bonislawski, D. P.; Skradski, S. L.; Araki, T.; Lan, J. Q.; Schindler, C. K.; Meller, R.; Simon, R. P. Formation of the Apaf-1/cytochrome c complex precedes activation of caspase-9 during seizure-induced neuronal death. Cell Death Differ. 2001, 8, 1169-1181. (Pubitemid 34048472)
34. Zhang, M. C.; Liu, H. P.; Demchik, L. L.; Zhai, Y. F.; Yang, D. J. Light sensitizes IFN-gammamediated apoptosis of HT-29 human carcinoma cells through both death receptor and mitochondria pathways. Cell Res. 2004, 14, 117-124.
35. Lazebnik, Y. A.; Kaufmann, S. H.; Desnoyers, S.; Poirier, G. G.; Eamshaw, W. C. Cleavage of poly (ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 1994, 371, 346-347. (Pubitemid 24300618)
36. Thati, B.; Noble, A.; Creaven, B. S.; Walsh, M.; McCann, M.; Devereux, M.; Kavanagh, K.; Egan, D. A. Role of cell cycle events and apoptosis in mediating the anti-cancer activity of a silver (I) complex of 4-hydroxy-3-nitro-coumarin-bis (phenanthroline) in human malignant cancer cells. Eur. J. Pharmacol. 2009, 602, 203-214.